Cowen analyst Timothy Arcuri noted that he has been writing about a potential Qualcomm (QCOM) acquisition of NXP Semiconductors (NXPI) for about 12 months and "would love to see it consummated" following reports that the companies are in talks. The analyst, who thinks a deal for NXP at a price of $115 paid for with a mix of cash and debt could be accretive to Qualcomm by more than 20%, raised his price target on Qualcomm shares to $74 from $62. Arcuri noted that Broadcom (AVGO) could be another potential NXP suitor, but he believes that a deal to buy Xilinx (XLNX) "makes much more sense" for Broadcom.

Susquehanna analyst Christopher Rolland raised the firm's price target on Impinj (PI) to $150 from $140 and keeps a Positive rating on the shares. The firm said they posted a solid print with additional upside driven by the licensing win from NXP Semiconductors (NXPI). Customer engagements and new RFID markets continue to broaden the opportunity.

BofA raised the firm's price target on Texas Instruments (TXN) to $190 from $175 and keeps a Neutral rating on the shares. TI's small Q1 beat and inline but sequentially rising Q2 sales guidance, "while modest, potentially marks a recovery inflection in industrial chip demand," with positive read-across for U.S. peers such as Analog Devices (ADI), Microchip (MCHP), NXP Semiconductors (NXPI) and On Semiconductor (ON), the analyst tells investors. However, despite an expected recovery, TI's sustained high capex intensity could keep reported calendar year 2024-26 pro-forma EPS below $6 per share, the analyst added.